You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.

Vol. 130 No. 1, January 2012

Online Only
	•	Online First Table of Contents

•	Online Features

This Article
•	Abstract
•	Full text
•	Reply to article
•	Send to a friend
•	Save in My Folder
•	Save to citation manager
•	Permissions

Citing Articles
•	Contact me when this article is cited

Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Arch Ophthalmol. 2012;130(1):9-24.

Author Interview

Author Interview - Dr Jacobson discusses his Clinical Trial on Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years

Listen to an mp3 of the interview. (07:32, 4.5 MB).

| | |